Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation
スポンサーリンク
概要
- 論文の詳細を見る
Human herpesvirus-6 (HHV-6) is a major cause of limbic encephalitis with a dismal prognosis after allogeneic hematopoietic stem cell transplantation (SCT). Because our previous trial of preemptive therapy with foscarnet sodium (phosphonoformic acid; PFA) failed to prevent HHV-6 encephalitis, we conducted a prospective study to examine the safety of prophylactic PFA administration and elucidate the changes in the plasma HHV-6 DNA levels in the early post-SCT period. Plasma HHV-6 DNA was measured thrice weekly from day 6. PFA, 90mg/kg/day, was administered from days 7 to 21 after bone marrow or peripheral blood SCT and to day 25 after umbilical cord blood transplantation. Of the 10 patients enrolled, 2 dropped out of the study, 1 because of early death, and 1 with a low glomerular filtration rate. Grade 3 or greater adverse events occurred in 9 of the 10 prophylactic PFA patients and in 7 of the 10 control patients who had clinical backgrounds similar to the study subjects and underwent SCT during the same period. Neurological disorders developed in none of the study subjects but in 4 of the 10 control patients, including 2 with HHV-6 encephalitis. HHV-6 reactivation occurred in 3 of the 10 study subjects. The prophylactic PFA regimen was thus safe and it may reduce the risk of limbic encephalitis, but is not considered to be potent enough to prevent HHV-6 reactivation. (C) 2011 John Wiley & Sons A/S.
論文 | ランダム
- Kleinert 変法による Zone II 両屈筋腱断裂の治療成績
- 26pRB-3 放射光X線回折実験による分子性導体α-(BEDT-TTF)_2I_3の電子状態の観測(26pRB 電荷秩序,領域7(分子性固体・有機導体))
- 25pPSA-30 擬一次元反強磁性体Cu_3Mo_2O_9の磁場中誘電率(25pPSA 領域3ポスターセッション,領域3(磁性,磁気共鳴))
- 5765 上海市の『廉租住房』政策とその効果(住宅政策・動向,建築計画II)
- 低所得者向け住宅手当について